Evidence map›Paper›PMID 25962889›Full record

Trial reportContemporary clinical trials2015

An exercise trial targeting African-American women with metabolic syndrome and at high risk for breast cancer: Rationale, design, and methods.

Chiranjeev Dash, Kepher Makambi, Sherrie F Wallington, Vanessa Sheppard, Teletia R Taylor, Jennifer S Hicks, Lucile L Adams-Campbell

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Contemporary clinical trials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02103140 (An Exercise Randomized Controlled Trial Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02103140 naunknown statusnot on this map

An Exercise Randomized Controlled Trial Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer

TypeinterventionalSponsorGeorgetown UniversityRan2012 to 2025Enrolled213ConditionsMetabolic Syndrome, ObesityArmsFacility-based Exercise, Home-based Exercise
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Exercise therapy in cancer prevention and treatment.Nature reviews. Clinical oncology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. MicroRNAs in cancer therapeutics: "from the bench to the bedside".Expert opinion on biological therapy · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Chiranjeev DashGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States. Electronic address: cd422@georgetown.edu.
Kepher MakambiGeorgetown Lombardi Comprehensive Cancer Center Biostatistics & Bioinformatics Shared Resource, Washington, D.C., United States.
Sherrie F WallingtonGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States.
Vanessa SheppardGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States.
Teletia R TaylorHoward University Cancer Center, Howard University, Washington, D.C., United States.
Jennifer S HicksGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States.
Lucile L Adams-CampbellGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States.
Georgetown University · USGeorgetown University Medical Center · USGeorgetown Lombardi Comprehensive Cancer CenterHoward University · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUUL1TR000101 · NCATS · GEORGETOWN UNIVERSITY · PI MELLMAN, THOMAS A, VERBALIS, JOSEPH G · 2012 to 2015
$19.3M
Subproject 2: Verifying Information and Communication Technology and Outcomes P60MD006920 · NIMHD · GEORGETOWN UNIVERSITY · PI ADAMS-CAMPBELL, LUCILE LAUREN, KIDWELL, CHELSEA S · 2012 to 2016
$6.3M
An HPV Health Communication Randomized Controlled Trial InterventionK01CA155417 · NCI · GEORGETOWN UNIVERSITY · PI WALLINGTON, SHERRIE LEE · 2011 to 2015
$659k
NCATS NIH HHS UL1 TR000101NCATS NIH HHS UL1TR000101NCI NIH HHS K01 CA155417NCI NIH HHS P30 CA051008NIMHD NIH HHS 1P60MD006920-01NIMHD NIH HHS P60 MD006920
6 · The paper itself

Abstract

backgroundMetabolic syndrome and obesity are known risk factors for breast cancers. Exercise interventions can potentially modify circulating biomarkers of breast cancer risk but evidence in African-Americans and women with metabolic syndrome is lacking. METHODS/

designThe Focused Intervention on Exercise to Reduce CancEr (FIERCE) trial is a prospective, 6-month, 3-arm, randomized controlled trial to examine the effect of exercise on obesity, metabolic syndrome components, and breast cancer biomarkers among African-American women at high risk of breast cancer. Two hundred-forty inactive women with metabolic syndrome and absolute risk of breast cancer ≥ 1.40 will be randomized to one of the three trial arms: 1) a supervised, facility-based exercise arm; 2) a home-based exercise arm; and 3) a control group that maintains physical activity levels through the course of the trial. Assessments will be conducted at baseline, 3 months, and 6 months. The primary outcome variables are anthropometric indicators of obesity, metabolic syndrome components, and inflammatory, insulin-pathway, and hormonal biomarkers of breast cancer risk. DISCUSSION: The FIERCE trial will provide evidence on whether a short-term exercise intervention might be effective in reducing breast cancer risk among African-American women with comorbidities and high breast cancer risk--a group traditionally under-represented in non-therapeutic breast cancer trials. CLINICAL TRIAL REGISTRATION NUMBER: NCT02103140.

Indexed as

Black or African AmericanExerciseBiomarkers, TumorBlood GlucoseBlood PressureBreast NeoplasmsFemaleHumansLipidsMetabolic SyndromeMiddle AgedObesityPostmenopauseProspective StudiesQuality of LifeResearch DesignBiomarkers, TumorBlood GlucoseLipidsAfrican-AmericanBreast cancerClinical trialMetabolic syndromePhysical activityRandomized controlled trial

Identifiers

PMID25962889
PMCPMC4522388
OpenAlexW212630721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.